Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medtronic PLC (MDT) vs Western Alliance Bancorporation (WAL) Price & Performance

Medtronic PLCTrade
Western Alliance BancorporationTrade

Price performance (Past 24H)

Key statistics

Medtronic PLC vs Western Alliance Bancorporation — how do they compare? Medtronic PLC trades at $82.79 (market cap $106.61B), while Western Alliance Bancorporation trades at $79.8 (market cap $8.84B). The key difference: Medtronic PLC is far larger — about 12.1× Western Alliance Bancorporation's market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.

MDTWAL
Market Cap
$106.61B$8.84B
Sector
HealthFinancials
52-Week High
$105.35$96.08
52-Week Low
$73.75$66.70
Enterprise Value
$125.36B
Dividend Yield
3.46%2.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medtronic PLC

No Aura AI signal available yet.

Western Alliance Bancorporation

Western Alliance Bancorporation (WAL) trades at $80.97, down 1.62% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company has consistently beaten earnings estimates in recent quarters, with a Q2 2026 EPS estimate of $2.33. Strong profitability is evident with a net income margin of 25.63% and ROE of 13.47%, while valuation ratios like a P/E of 9.58 suggest potential undervaluation. Recent news highlights operational achievements, including being named Arizona's #1 bank by Forbes in June 2026.

The outlook for WAL is positive, supported by analyst consensus with 79% buy ratings and a $90.67 price target, implying ~12% upside. Investment opportunities include earnings growth and sector leadership, but risks involve negative operating cash flow in 2025 and high interest expenses of $1.83B that could pressure margins if rates rise.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT

About Western Alliance Bancorporation

Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.

Read more on WAL